Search

everythinglearnresearchcommunity

for

Search:↓

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

CTP-543 is generally safe for treating alopecia areata.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

CMV infection increases the risk of GvHD after bone marrow transplants.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Indinavir and ritonavir therapy can cause reversible hair loss.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Deucravacitinib helped a man regrow hair and improve psoriasis.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

The FDA approved a new Pfizer drug for hair loss in teens.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Higher CRBP1 levels are linked to more severe alopecia areata.